Biodistribution and toxicity assessment of europium-doped Gd 2O3 nanotubes in mice after intraperitoneal injection

Journal of Nanoparticle Research

Volumn 16, Issue 3, 2014, Pages

  Liu, Huifang ^a   Zhang, Cuimiao ^a   Tan, Yanli ^a   Wang, Jianguo ^a   Wang, Ke ^b   Zhao, Yanyan ^a   Jia, Guang ^a   Hou, Yingjian ^a   Wang, Shuxian ^a   Zhang, Jinchao ^a  

^a HEBEI UNIVERSITY   (China)

^b Shijiazhuang Center for Disease Control and Prevention   (China)

Author keywords

Biodistribution; Gadolinium oxide; In vivo; Mice; Nanotubes; Toxicity

Indexed keywords

BIOLOGICAL ORGANS; CELL DEATH; CELL PROLIFERATION; EUROPIUM; EUROPIUM COMPOUNDS; MAMMALS; MEDICINE; NANOTUBES; TOXICITY;

BIOCHEMICAL PARAMETERS; BIODISTRIBUTIONS; EXPERIMENTAL GROUPS; GADOLINIUM OXIDE; IN-VIVO; INTRAPERITONEAL INJECTIONS; MICE; TOXICITY ASSESSMENT;

GADOLINIUM COMPOUNDS;

2 HYDROXYBUTYRATE DEHYDROGENASE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; EUROPIUM; GADOLINIUM; LACTATE DEHYDROGENASE; NANOTUBE; URIC ACID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIOCHEMICAL COMPOSITION; CELL PROLIFERATION; CONTROLLED STUDY; DISTRIBUTION VOLUME; ENVIRONMENTAL TEMPERATURE; FEMALE; HEART MUSCLE ISCHEMIA; HEMATOLOGICAL PARAMETERS; HISTOPATHOLOGY; KIDNEY DISEASE; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER NECROSIS; LUNG HEMORRHAGE; MESANGIUM CELL; MOUSE; NANOTOXICOLOGY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SPLEEN; SPLEEN DISEASE; TOXICITY TESTING; URIC ACID BLOOD LEVEL;

EID: 84896493643     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-014-2303-8     Document Type: Article

References (33)

1. Abraham JL, Thakral C, Skov L, Rossen K, Marckmann P (2008) Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis. Br J Dermatol 158:273-280
2. Aillon KL, Xie Y, El-Gendy N, Berkland CJ, Forrest ML (2009) Effects of nanomaterial physicochemical properties on in vivo toxicity. Adv Drug Deliv Rev 61:457-466
3. 22]n nanoparticles: antineoplastic activity of high efficiency and low toxicity. Nano Lett 5:2050-2057
4. Cowper SE, Rabach M, Girardi M (2008) Clinical and histological findings in nephrogenic systemic fibrosis. Eur J Radiol 66:191-199
5. Fischer HC, Chan WC (2007) Nanotoxicity: the growing need for in vivo study. Curr Opin Biotechnol 18:565-571
6. 3+ nanostructures for biomedical applications. J Mater Sci Mater Med 23:2399-2412
7. Hirst SM, Karakoti A, Singh S, Self W, Tyler R, Seal S, Reilly CM (2013) Bio-distribution and in vivo antioxidant effects of cerium oxide nanoparticles in mice. Environ Toxicol 28:107-118
8. Idée JM, Port M, Raynal I, Schaefer M, Le Greneur S, Corot C (2006) Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review. Fundam Clin Pharmacol 20:563-576
9. 3+ nanotubes: facile synthesis and luminescence properties. J Phys Chem C 113:6050-6055
10. Krug HF, Wick P (2011) Nanotoxicology: an interdisciplinary challenge. Anqew Chem Int Ed Enql 50:1260-1278
11. Le UM, Cui Z (2006) Long-circulating gadolinium-encapsulated liposomes for potential application in tumor neutron capture therapy. Int J Pharm 312:105-112
12. Magda D, Miller RA (2006) Motexafin gadolinium: a novel redox active drug for cancer therapy. Semin Cancer Biol 16:466-476 (Pubitemid 44780135)
13. Nakamura Y, Tsumura Y, Tonoqai Y, Shibata T, Ito Y (1997) Differences in behavior among the chlorides of seven rare earth elements administered intravenously to rats. Fundam Appl Toxicol 37:106-116
14. Palasz A, Czekaj P (2000) Toxicological and cytophysiological aspects of lanthanides action. Acta Biochim Pol 47:1107-1114
15. Patra CR, Abdel Moneim SS, Wang E, Dutta S, Patra S, Eshed M, Mukherjee P, Gedanken A, Shah VH, Mukhopadhyay D (2009) In vivo toxicity studies of europium hydroxide nanorods in mice. Toxicol Appl Pharmacol 240:88-98
16. Pradhan AK, Zhang K, Bahoura M, Pradhan J, Ravichandran P, Gopikrishnan R, Ramesh GT (2011) Synthesis, characterization, toxicity of nanomaterials for biomedical applications. In: Anthony L (ed) Biomedical engineering, trends in materials science. Intech, Rijeka, pp 348-374
17. Rada S, Rada M, Culea E (2011) Structural and optical properties of the gadolinium-lead-germanate glasses. J Non-Cryst Solids 357:62-66
18. Radford IR (2000) Gd-Tex Pharmacyclics Inc. Curr Opin Investiq Drugs 1:524-528
19. Samet JM, Dominici F, Curriero FC, Coursac I, Zeger SL (2000) Fine particulate air pollution and mortality in 20 U.S. cities, 1987-1994. N Engl J Med 343:1742-1749 (Pubitemid 32369215)
20. Sarkar A, Das J, Manna P, Sil PC (2011) Nano-copper induces oxidative stress and apoptosis in kidney via both extrinsic and intrinsic pathways. Toxicology 290:208-217
21. Sessler JL, Miller RA (2000) Texaphyrins: new drugs with diverse clinical applications in radiation and photodynamic therapy. Biochem Pharmacol 59:733-739 (Pubitemid 30081696)
22. Sharma P, Brown SC, Walter G, Santra S, Scott E, Ichiwaka H, Fukumori Y, Moudgil BM (2007) Gd nanoparticulates: from magnetic resonance imaging to neutron capture therapy. Adv Powder Technol 18:663-698 (Pubitemid 350112907)
23. Sherry AD, Caravan P, Lenkinski RE (2009) Primer on gadolinium chemistry. J Magn Reson Imaging 30:1240-1248
24. Sung JH, Ji JH, Park JD, Yoon JU, Kim DS, Jeon KS, Song MY, Jeong J, Han BS, Han JH, Chung YH, Chang HK, Lee JH, Cho MH, Kelman BJ, Yu IJ (2009) Subchronic inhalation toxicity of silver nanoparticles. Toxicol Sci 108:452-461
25. Thomsen HS (2004) Gadolinium-based contrast media may be nephrotoxic even at approved doses.EurRadiol 14:1654-1656
26. Von Klot S, Wolke G, Tuch T, Heinrich J, Dockery DW, Schwartz J, Kreyling WG, Wichmann HE, Peters A (2002) Increased asthma medication use in association with ambient fine and ultrafine particles. Eur Respir J 20:691-702
27. Wang H, Wang J, Deng X, Sun H, Shi Z, Gu Z, Liu Y, Zhao Y (2004) Biodistribution of carbon single-wall carbon nanotubes in mice. J Nanosci Nanotechnol 4:1019-1024 (Pubitemid 40056461)
28. Wang B, Feng WY, Wang TC, Jia G, Wang M, Shi JW, Zhang F, Zhao YL, Chai ZF (2005) Acute toxicity of nano- and micro-scale zinc powder in healthy adult mice. Toxicol Lett 161:115-123 (Pubitemid 41794044)
29. Wang J, Chen C, Li B, Yu H, Zhao Y, Sun J, Li Y, Xing G, Yuan H, Tang J, Chen Z, Meng H, Gao Y, Ye C, Chai Z, Zhu C, Ma B, Fang X, Wan L (2006) Antioxidative function and biodistribution of [Gd@C82(OH)22]n nanoparticles in tumor-bearing mice. Biochem Pharmacol 71:872-881 (Pubitemid 43208844)
30. Wang J, Zhou G, Chen C, Yu H, Wang T, Ma Y, Jia G, Gao Y, Li B, Sun J, Li Y, Jiao F, Zhao Y, Chai Z (2007) Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. Toxicol Lett 168:176-185 (Pubitemid 46075175)
31. Wang B, Feng W, Wang M, Wang T, Gu Y, Zhu M, Ouyang H, Shi J, Zhang F, Zhao Y, Chai Z, Wang H, Wang J (2008) Acute toxicological impact of nano- and submicro-scaled zinc oxide powder on healthy adult mice. J Nanopart Res 10:263-276 (Pubitemid 350292630)
32. Yokel RA, Au TC, MacPhail R, Hardas SS, Butterfield DA, Sultana R, Goodman M, Tseng MT, Dan M, Haghnazar H, Unrine JM, Graham UM, Wu P, Grulke EA (2009) Distribution, elimination, and biopersistence to 90 days of a systemically introduced 30 nm ceria-engineered nanomaterial in rats. Toxicol Sci 127:256-268
33. 3 and FeCo nanoparticles for biomedical application. Proc of SPIE 7291:729104-729110